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Abstract
  
 Hyptis pectinata (L.) poit, popularly known in the world as “comb bushmint” is a 
medicinal plant commonly used for the treatment of throat and skin inflammations, bacterial 
infection, pain and cancer. The objective of this research is to determine the cytotoxic and 
antiproliferative effect of Hyptis pectinata ethanolic extract (HPE) on breast cancer cells. 
The effect HPE on cytotoxicity was examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-dphenyl 
tetrazolium bromide (MTT) assay on michigan cancer foundation (MCF-7) breast cancer 
cells. This assay also used to determine cell proliferation over 3 days of treatment with HPE 
concentration between 1.5–100 µg/mL. HPE showed that exhibited cytotoxic effects with 
IC50 value of 46 µg/mL for 24 h and changes the physiological morphology on MCF-7 cells. 
Interestingly, the treatment of HPE for 48 and 72 h highly decreases cell viability on MCF-7 
with dose and time-dependent manner compared to untreated cells. These results indicate 
that HPE has antiproliferative activities and maybe the potential to be used in drug design in 
an attempt to develop new compounds with fewer side effects when compared to conventional 
chemotherapy. 
Keywords: Hyptis pectinata (L.) poit extract, cytotoxicity, antiproliferative, MCF-7 cells  
Submitted: October 24, 2019
Revised: December 9, 2019
Accepted: December 10, 2019
*Corresponding author: meiny_suzery@yahoo.com
INTRODUCTION
 Breast cancer is the most leading death 
cancer in the women. In 2018 new cases of 
cancer accounting 1.67 million and 0.5 million 
cancer-related death among women (Bray, et al., 
2018). In Indonesia, have the same phenomenon, 
approximately 30.5% of all cancer diagnosed and 
21.5% of cancer-related deaths (Krok-schoen, et 
al., 2016). Early diagnostic procedures and effective 
screening can prevent the severity of breast cancer. 
Unfortunately, breast cancer diagnosed at a late stage 
in many patients (migration stage), and there is no 
effective curative treatment (Huang, et al., 2017). 
In Indonesia, chemotherapy is one of the common 
treatments for breast cancer at all stages, but this 
treatment have many adverse side effects such as 
hepatotoxicity, cognitive dysfunctions, fatigue, 
and reduction in quality of  life  ratings (Kayl  and 
Meyers, 2006). Hence, there is an urgent need to 
discover new anticancer drug leads. 
 Plant extracts and derived active 
principles have served as a major source for 
new pharmaceuticals for treatment of malignant 
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tumors. Hyptis pectinata (L.) poit has more 
than 400 species distributed in tropical climates 
such as Indonesia, 146 are endemic to brazil and 
popularly known as “sambacaita” (Porter, et al., 
1995; Pålsson and Jaenson, 1999; De Almeida 
and De Albuquerque, 2002). Hyptis pectinata is 
a medicinal plant popularly used for anticancer, 
antioxidant, anti-inflammatory, antiociceptive, and 
antimicrobial (Miranda, et al., 1993; Santos, et 
al., 2008; Raymundo, et al., 2011; Santana, et al., 
2019). Hyptis pectinata extract (HPE) is capable on 
inhibiting the growth of  human colon carcinoma 
cell line (HCT-8) with moderate cytotoxic activity 
(Barbosa, et al., 2012). Based on the above data, there 
is no one information about the potential of HPE on 
human breast cancer cells. Hence, the objective of 
the present study was to analyze the cytotoxic and 
anti-proliferative activity of HPE on human breast 




 Hyptis pectinata (L.) poit (plant genus: 
Hyptis, plant family: Labiate) (Steenis, 1992) was 
collected in Kanayakan village, Bandung West 
Java, Indonesia. Voucher specimen (MS 100562) 
was deposited at the herbarium Biology, Faculty 
Sains and Mathematic, Diponegoro University, 
Semarang, Indonesia. The leaves of Hyptis 
pectinata, were dried at 45oC and mashed into 
powder. Dried powdered leaves was extracted by 
maceration with ethanol at room temperature. After 
filtration, the solvent was evaporated under reduce 
pressure in a rotary  vacuum evaporator to result the 
crude extracts of the plant (Achmad, et al., 1987; 
Suzery, et al., 2012). 
Cell Culture
 MCF-7 was obtained from the American 
Type Culture Collection (ATTC® HTB-22TM) 
(Manassas, Virginia, USA). The cell culture 
methods was adapted from (Khamsita, et al., 
2012) with slightly modification. Briefly, MCF-
7 cells was cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Gibco, New York, 
USA) supplemented with 10% (v/v) fetal bovine 
serum (FBS) (Gibco), 150 IU/mL penicillin, 150 
µg/mL Streptomycin (Gibco) and 12,5 µg/mL 
Amphotericin B (Gibco). Cells were grown at 
370C with 5% CO2 in a humidified atmosphere.
Cytotoxic Assay
 The cytotoxicity of HPE was tested 
using 3-(4,5-dimethylthiazol-2-yl)-2,5-dphenyl 
tetrazolium bromide (MTT) assay according to 
(Mosmann, 1983) with slight modifications. MCF-
7 cells (2x104) were seeded in 96-well microplate 
and divided into an untreated and treated groups. 
After 24 h of incubation, the medium replaced 
with a series of concentrations of HPE. Cells were 
treated with HPE (1.562; 3.125; 6.25; 12.5; 25; 50; 
and 100 µg/mL). Untreated cells were regarded 
as negative controls. After 24 h of treatment, the 
medium was discarded and replaced with 0.5 mg/
mL of MTT (Biovision, California, USA) and 
incubated for approximately four hours at 370C, 5% 
CO2. Cells were lysed using 10% sodium dodecyl 
sulfate (SDS) stopper containing 0.01 NHCl and 
incubated in the dark condition overnight to dissolve 
formazan salt. After incubation, the absorbance 
was measured by Enzyme-linked Immunosorbent 
Assay (ELISA) reader plate at λ 550 nm. The 
absorbance was converted to % cell viability by 
comparing the treated group with the untreated at 
a particular time course. Linear regression between 
concentration (x) and % cell viability (y), giving 
the equation y=Bx+A were used to calculate IC50 
value. Using the linier equation of this graph for 
y=50 value x point becomes IC50 value, that is the 
concentration inhibiting 50% cell proliferation. The 
data of this study was carried out with 3 replication 
experiments. 
Proliferation Assay
 In the experiments to measure proliferation 
rates, 5x104 MCF-7 cells were seeded in 96-well 
microplate as described above and treated with HPE 
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at several concentration (1.562–100 µg/mL) for 24, 
48, and 72 h before MTT. The data of this study was 
carried out with 3 replication experiments.
Statistical Analysis
 The data were expressed as the 
mean±standard error of the mean (SE) of 3 
experiments. One-way analysis of variance followed 
by the least significant difference test was used for 
statistical analyses (Microsoft, Redmond, USA). P 
values less than 0.05 were considered statistically 
significant. 
RESULTS
 The objective of this research was to 
develop HPE as a novel natural chemotherapeutic 
agent for breast cancer. To determine the cytotoxic 
activity of HPE, MCF-7 breast cancer cells 
incubated in the presence (1.562 to 100 µg/mL) 
of HPE in vitro for 24 h. The cytotoxic activity 
was analyze under MTT assay, and the IC50 value 
presented the cytotoxic effect of HPE. The treatment 
with HPE for 24 h induced morphological changes 
(Figure 1). HPE at the middle concentration 
(25 µg/mL) induced cell shrinkage and high 
concentration (100 µg/mL) there was more number 
of cell shrinkage and fragmentation. However, the 
untreated and low concentration (1.562 µg/mL) 
did not show morphological changes. In addition, 
treatment of HPE  for  24 h  revealed  cytotoxic 
effect on MCF-7 cells with IC50 value of 46 µg/
mL (Figure 2A). HPE higher than 12.5 µg/mL 
significantly suppressed the growth of MCF-7 cells 
compare with untreated cells as negative control.
Following treatment of the MCF-7 cells with 
ethanolic extracts for 24 h, the morphology 
of cells altered clearly especially at higher 
concentrations. The detached round cells which 
were floating in the medium with the wrinkled 
nucleolus, bubbled membrane as well as decries, 
were obliviously seen in the MCF-7 cells. Such 
morphological features, which are sign of cell 
death and were not seen in the untreated cells. 
 Based on the data, further investigating the 
effect of HPE on the anti-proliferative effect after 
24, 48, and 72 h of HPE treatment. For this purpose, 
MCF-7 cells cultured in the presence of HPE at the 
various time of treatment. Figure 2B shows that, 
HPE highly suppressed cell proliferation with IC50 
value 42 µg/mL, 30 µg/mL, and 17 µg/mL for 24, 
48 and 72 h treatment, respectively. Therefore, we 
concluded that HPE exhibit strong cytotoxic activity 
in dose and time dependent manner on MCF-7 cells.
Figure 1. The effect of HPE on MCF-7 cell morphology. MCF-7 cells (2x104) were seeded in 96 well plate and incubate 
for 24 h, then treated with HPE (1.562-100 µg/mL) for 24 h. Obvious morphological changes and cell population 
in the treatment of HPE concentration of untreated, low concentration (1.562 µg/mL), middle concentration 
(25 µg/mL), and high concentration (100 µg/mL). Black arrows indicated normal living cells, whereas red arrows 
indicated the cell morphological changes. HPE at the middle concentration (25 µg/mL) induced cell shrinkage 
and high concentration (100 µg/mL) there was more number of cell shrinkage and fragmentation. Cell mor-
phology observations conducted with an inverted microscope with a magnification of 100x. Scale bar: 100 µm. 
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DISCUSSION
 
 Nowdays, it is important to explore new 
source of natural medicines because the demand for 
such drugs is increasing. Plants are rich source of 
anticancer agents and many of the anticancer drug 
in the market are derived from them (Lampronti, 
et al., 2006; Newman and Cragg, 2007; Pan, et al., 
2010). In the past few years, a number of herbal 
medicines with potent anti-cancer activity were 
reported, such as Hyptis pectinata (Santana, et al., 
2019). Previous study revealed that HPE could 
suppress human colon carcinoma HCT-8 cells with 
moderate cytotoxic activity (Barbosa, et al., 2012). 
Previous research also reported that pectinolide 
(one of the isolate compound from Hyptis pecti-
nata (L.) poit) has a cytotoxic effect on triple-neg-
ative human breast cancer MDA MB 231 cells, and 
pectinolide often has significant cytotoxic activity 
against the colon, fibro sarcoma, and lung cells with 
IC50 value of <4 µg/mL (Miranda, et al., 1993; San-
tana, et al., 2019). Inhibition of cancer growth has 
been a continuous effort in cancer treatment. Re-
ducing cell growth are a major way of inhibiting 
cancer growth (Huang, et al., 2003). In this study, 
cytotoxic activity of HPE was observed on human 
breast cancer cells with several time of treatment. 
 In order to evaluate whether HPE could 
exert an anti-cancer effect on breast cancer, breast 
cancer cell lines were used, such as MCF-7 estro-
gen receptor positive (ER+). The addition of HPE 
to MCF-7 increased the cell mortality in a doses-de-
pendent manner for 24 h with IC50 value of 42 µg/
mL. Interestingly, in this research found that the 
ethanolic extract of Hyptis pectinata to be more ef-
fective than the methanolic extract (IC50 value of 
185.63 µg/mL) in inhibiting breast cancer MCF-7 
cells (Suzery and Cahyono, 2014). This activity 
might be due to influence of ethanolic extract of 
Hyptis pectinata may modulate estrogen receptor 
activation and more importantly estrogen-depen-
dent breast tumors (Popolo, et al., 2009). In another 
hand, hyptolide and pectinolide compounds as the 
major metabolites of HPE  also affect cytotoxic ac-
tivity (Miranda, et al., 1993; Asy, et al., 2019). 
 Thus, based on these results cell prolifera-
tion was observed in several time variation of HPE 
treatment, for 24, 48, and 72 h. The ethanolic extract 
had an outstanding inhibitory effect on proliferation 
with IC50 value 42 µg/mL, 30 µg/mL, and 17 µg/
Figure 2. Effect of HPE on the cell viability of MCF-7 cells. (A) MCF-7 cells (2x104 cells/mL) were culture in pres-
ence of HPE (1.562–100 µg/mL) for 24 h, HPE performed cytotoxic effect with IC50 value of 46 µg/mL. (B) MCF-7 
cells (2x104 cells/mL) in 96-well plates for 24 h to adapt, then treated with HPE concentrations of 1.5625–100 
µg/mL, then incubated again for 24 h, 48 h, and 72 h. Profiles of cell viability expressed mean±SD of 3 exper-
iments. IC50 obtained from the linear regression calculation of cell viability vs log concentrations with p<0.05.
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mL for 24, 48 and 72 h treatment, respectively. The 
low percentage of live cells observed in the treated 
cells show effective proliferation activity of the 
plant extract against the MCF-7 cells. For 72 h, the 
concentration required to reduce the growth of the 
MCF-7 cells to 50% was 17 μg/mL. This concen-
tration is considered to be very low, as according 
to the American National Cancer Institute, a value 
of 30 μg/mL is the highest IC50 that is considered 
promising when searching for activity in the whole 
extract (Kuete, et al., 2013). According to the pre-
vious studies, HPE is a rich source of hyptolide. 
This compound is that the decrease in cell viability 
may be due to the influence of α-tubulin inhibition 
caused by hyptolide treatment as a consequence of 
its cell proliferation (Meiny, et al., 2012; Asy, et al., 
2019). Collectively, our results demonstrated that 
HPE has cytotoxic and anti-proliferative activity 
against human breast cancer cells, and maybe can 
be used in drug design in an attempt to develop new 
compounds with fewer side effects when compared 
to conventional chemotherapy. Further studies are 
necessary for mechanism of cell death characteri-
zation and in vivo evaluation to identify effective 
anticancer of HPE. 
CONCLUSION
 The HPE has potential inhibited cell growth 
of human breast cancer MCF-7 cells. Furthermore, 
Hyptis pectinata can be used in drug design in an 
attempt to develop new compounds with fewer 
side effects when compared to conventional 
chemotherapy. 
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